Nadja Mannowetz

CO FOUNDER & CSO @ YourChoice Therapeutics arrow icon

Nadja Mannowetz is the co-founder and Chief Scientific Officer (CSO) who holds a PhD.

Nadja Mannowetz's Title

Nadja Mannowetz holds the prestigious position of CO FOUNDER & Chief Scientific Officer (CSO). In this role, she is responsible for driving the scientific vision and strategy of the company. Her leadership is pivotal in steering research and development, ensuring that the company's scientific endeavors are innovative and impactful. As a CSO, Nadja Mannowetz collaborates with other key stakeholders to align scientific goals with business objectives, fostering a culture of excellence in research.

Nadja Mannowetz's Company

Nadja Mannowetz is the CO FOUNDER of a forward-thinking company, where she plays a crucial role in its establishment and growth. Her contributions as a co-founder are instrumental in shaping the company's mission and strategic direction. Nadja's entrepreneurial spirit and scientific expertise drive the company's innovative solutions, making a significant impact in its industry. The company benefits from her deep understanding of scientific research, which informs its product development and market strategy.

Nadja Mannowetz's Education and Expertise

Nadja Mannowetz holds a PhD, underscoring her extensive academic background and deep expertise in her field. Her advanced education has equipped her with a robust foundation in scientific research and a thorough understanding of complex concepts. This high level of expertise enables her to lead cutting-edge research projects and contribute valuable insights to her company's strategic initiatives. Nadja's academic achievements highlight her dedication to advancing knowledge and her commitment to scientific excellence.

report flag Report inaccurate information

People similar to Nadja Mannowetz

Akash Bakshi is the Co-Founder and CEO of his company, holding a Master of Science degree.

Eric Ruby is a professional in the regulatory field, holding a PhD.

William Breslin is a toxicologist with a PhD, specializing in the development of non-hormonal contraceptives.